James Hunt, MD
Critical Care Medicine · Greenwood Village, CONPI 1437205069
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Intuitive Surgical at 56.4% of the total. Reporting peaked in 2023 at $5,736 and has fallen 89.4% since, to $608 in 2025.
Across 98 payments — averaging $93.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Inari Medical, Inc.$878
- Actelion Pharmaceuticals US, Inc.$581
- AstraZeneca$316
- Bayer$273
- GSK$185
- plus $2K from 18 others
What the payments were for
- Consulting fees$2002%
- Travel & lodging$1,86720%
- Food & beverage$4,07144%
- Education$3,02033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $5,163 |
| Inari Medical, Inc. | 6 | $878 |
| Actelion Pharmaceuticals US, Inc. | 8 | $581 |
| AstraZeneca | 11 | $316 |
| Bayer | 4 | $273 |
| GSK | 6 | $185 |
| Abiomed | 2 | $176 |
| Veran Medical Technologies, Inc. | 1 | $165 |
| Abbott | 1 | $143 |
| Siemens Medical Solutions USA, Inc. | 1 | $138 |
| Merck | 2 | $135 |
| Sanofi | 6 | $132 |
| Edwards Lifesciences | 1 | $130 |
| Inspire Medical Systems, Inc. | 1 | $119 |
| Pulmonx Corporation | 1 | $109 |
| Grifols USA, LLC | 5 | $109 |
| United Therapeutics Corporation | 5 | $84 |
| Insmed, Inc. | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| Harmony Biosciences LLC | 1 | $46 |
| Scpharmaceuticals Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $36 |
| Liquidia Technologies, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$1,630
- FLOWTRIEVER CATHETER, S$820
- CT THROMBECTOMY SYSTEM KIT$820
- OPSUMIT$237
- UPTRAVI$237
- Adempas$200
- Spin$165
- XACT$143
- Impella$143
- TEZSPIRE$125
- NUCALA$124
- WINREVAIR$120
- Inspire Upper Airway Stimulation System$119
- CHARTIS CATHETER$109
- ZEPHYR DELIVERY CATHETER$109
- ZEPHYR ENDOBRONCHIAL VALVE$109
- PULMONX CHARTIS TABLET CONSOLE$109
How this compares
$9,158 in reported general payments places this provider in the 85th percentile of 141 critical care medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AdempasRiociguat | 20 | $278,925 |
| Pirfenidone | 21 | $62,799 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $53,611 |
| Ambrisentan | 24 | $49,140 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $28,748 |
| Incruse ElliptaUmeclidinium Bromide | 37 | $17,934 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $11,706 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $9,583 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $8,871 |
| Mycophenolate Mofetil | 23 | $3,877 |
| Sildenafil Citrate | 19 | $1,234 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $652 |
| Prednisone | 22 | $104 |
| Furosemide | 32 | $80 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerAdempas | $273 | $278,92520 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $185 | $83,251105 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $316 | $37,61839 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 141 critical care medicine providers in Colorado.
Other critical care medicine in Greenwood Village
- Chakradhar KotaruGreenwood Village$61K
- Surit SharmaGreenwood Village$20K
- Isham HuizarGreenwood Village$6K
- Dylan PearsonGreenwood Village$5K
- Gregory MargolinGreenwood Village$5K
- Andrew LabelleGreenwood Village$3K
- Ahmad AlsaleemGreenwood Village$3K
- Akshay VijayaramanGreenwood Village$2K
- Fnu Arjun SaradnaGreenwood Village$2K
- Nathaniel PascualGreenwood Village$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.